sema3a pathway components sema3a (Shanghai Korain Biotech Co Ltd)
Structured Review
Sema3a Pathway Components Sema3a, supplied by Shanghai Korain Biotech Co Ltd, used in various techniques. Bioz Stars score: 93/100, based on 4 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sema3a/Human+Semaphorin+3A/10__3390_slash_metabo16100723-90-26-46
Average 93 stars, based on 4 article reviews
Images
Related Articles
Expressing:Article Title: Betaine induces apoptosis via ROS-independent mechanisms in U87 glioblastoma cells: a potential metabolic anticancer strategy Article Snippet: .. After 48 hours, the expression levels of Enzyme-linked Immunosorbent Assay:Article Title: Betaine induces apoptosis via ROS-independent mechanisms in U87 glioblastoma cells: a potential metabolic anticancer strategy Article Snippet: .. After 48 hours, the expression levels of Article Title: A newly synthesized compound induces apoptosis in prostate cancer cells by targeting mitochondrial dysfunction and the TP53/BCL-2/SEMA3 pathways. Article Snippet: Recent investigations have emphasized the therapeutic potential of thiazole derivatives in oncology.. In this study, the novel compound 2-[(4,5-dihydrothiazol-2-yl)thio]-N-(4-methylthiazol-2-yl)acetamide was evaluated for its cytotoxic and mechanistic effects on PC-3 prostate cancer cells.. Cell viability decreased significantly after treatment (****p ≤ 0.0001), and HEK-293 cells showed relative resistance at lower doses. Incubation:Article Title: A newly synthesized compound induces apoptosis in prostate cancer cells by targeting mitochondrial dysfunction and the TP53/BCL-2/SEMA3 pathways. Article Snippet: Recent investigations have emphasized the therapeutic potential of thiazole derivatives in oncology.. In this study, the novel compound 2-[(4,5-dihydrothiazol-2-yl)thio]-N-(4-methylthiazol-2-yl)acetamide was evaluated for its cytotoxic and mechanistic effects on PC-3 prostate cancer cells.. Cell viability decreased significantly after treatment (****p ≤ 0.0001), and HEK-293 cells showed relative resistance at lower doses. |

